Form 4 for MDT Medtronic
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001127602-21-023100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-04 | 2021-08-02 | MDT | Kuntz Richard | SVP, Chief Medical, Science | A - Grant | $0.00 | +5,029 | 74.9K | +7% | $0 |
| D | 2021-08-04 | 2021-08-02 | MDT | Kuntz Richard | SVP, Chief Medical, Science | F - Tax | $131.31 | -4,905 | 69.9K | -7% | -$644.1K |
| DM | 2021-08-04 | 2021-08-02 | MDT | Kuntz Richard | SVP, Chief Medical, Science | A - Grant | $0.00 | +56.6K | 1,085 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-08-02 | A | A | 5,029 | $0.00 | 74,915 | D | — | — | |
| 2 | Common | Ordinary Shares | 2021-08-02 | F | D | 4,905 | $131.31 | 69,886 | D | — | — | (F1) This balance increased by 782 shares due to exempt transactions such as dividend reinvestment. |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 42,961 | $0.00 | 42,961 | D | $131.26 · 2022-08-02 to 2031-08-02 | 42,961 Ordinary Shares | (F3) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |
| 4 | Derivative | Performance Share Units | 2021-08-02 | A | A | 12,571 | $0.00 | 12,571 | D | — · — to — | 12,571 Performance Share Units | (F5) The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 12,571 shares will be issued. The actual number of shares to be issued could range from a low of 2,515 at minimum performance to a high of 25,142 shares at maximum performance. If minimum performance metrics are not met, such PSUs may vest at 0 shares. (F4) Each performance share unit represents a contingent right to receive one share of Medtronic common stock. (F6) Vests on August 2, 2024. |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-08-02 | A | A | 1,085 | $0.00 | 1,085 | D | $131.26 · 2022-08-02 to 2031-08-02 | 1,085 Ordinary Shares | (F3) These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. |